Glaucoma News and Research

Latest Glaucoma News and Research

Altitude sickness drug may offer significant gains for patients with glioblastoma

A drug used to treat altitude sickness -- as well as glaucoma, epilepsy, heart failure and seizures -- may also offer significant gains for patients with a fast-growing brain tumor known as glioblastoma, according to a study published July 4, 2018, in the journal Science Translational Medicine.

10 Jul 2018

Ocular Therapeutix resubmits NDA for DEXTENZA

Ocular Therapeutix™, Inc., a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, has announced the resubmission of the Company's New Drug Application to the U.S. Food and Drug Administration for its lead product candidate DEXTENZA™ 0.4mg, for the treatment of ocular pain following ophthalmic surgery.

30 Jun 2018

Scientists provide clear picture of mysterious component of the inner ear

A few years ago, Ian Swinburne, HMS research fellow in systems biology, noticed something odd while conducting a time-lapse microscopy study of the inner ear of zebrafish. A tiny structure in the inner ear was pulsing like clockwork, inflating and deflating over and over.

29 Jun 2018

UH scientist receives grant to examine understudied part of glaucoma

UH College of Optometry biomedical engineer Vijaykrishna Raghunathan has received $765,000 from the National Institutes of Health to examine an understudied part of glaucoma - the ebb and flow of aqueous humor, the liquid in the eye whose regulation controls eye pressure.

20 Jun 2018

Persistent psychological stress contributes to development and progression of vision loss

Persistent psychological stress, which is widely recognized as a consequence of vision loss, is also a major contributor to its development and progression, according to a study now published in the EPMA Journal, the official journal of the European Association for Predictive, Preventive, and Personalized Medicine.

19 Jun 2018

Diabetes diagnosis may come with increased risk of pancreatic cancer for African-Americans, Latinos

Each year, more than one million Americans are diagnosed with adult-onset diabetes mellitus, also known as type 2 diabetes. The new diagnosis comes with a long list of potential complications: high blood pressure, nerve damage, kidney disease, stroke, glaucoma and more.

18 Jun 2018

EyeSouth announces strategic partnership with South Georgia / North Florida Eye Partners

EyeSouth Partners is pleased to announce that it has completed a strategic partnership with South Georgia / North Florida Eye Partners and Cataract and Laser Surgery Center of South Georgia, expanding its presence into the South Georgia and North Florida regions.

8 Jun 2018

Study reveals 133 genetic variants that may improve risk prediction for glaucoma

Researchers funded by the National Eye Institute have identified 133 genetic variants that predict with 75-percent accuracy a person's risk for developing glaucoma related to elevated pressure within the eye.

31 May 2018

FDA approves first stand-alone prosthetic iris in the U.S.

The U.S. Food and Drug Administration today approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris (the colored part of the eye around the pupil) is completely missing or damaged due to a congenital condition called aniridia or other damage to the eye.

30 May 2018

Researchers seek new approaches to better protect the eye from glaucoma

Under the increased pressure of glaucoma, scientists want to help the neurons in our eyes better protect themselves and get better help from their friends.

29 May 2018

Lack of insurance exposes blind spots in vision care

Every day, a school bus drops off as many as 45 children at a community eye clinic on Chicago's South Side. Many of them are referred to the clinic after failing vision screenings at their public schools.

15 May 2018

New lab-on-a-chip device shows promise in treating retinal diseases

Houston Methodist researchers developed a new lab-on-a-chip technology that could quickly screen possible drugs to repair damaged neuron and retinal connections, like what is seen in people with macular degeneration or who've had too much exposure to the glare of electronic screens.

10 May 2018

Sylentis presents clinical study results of new treatment for dry eye syndrome

Sylentis, Pharmaceutical Company belonging to the PharmaMar Group, has presented results from the clinical studies carried out with tivanisiran for the treatment of dry eye syndrome and that has enabled the start-up of the Phase III "Helix" clinical trial.

3 May 2018

Researchers develop new methods to diagnose glaucoma and detect disease progression

Two new research studies demonstrate that imaging technologies can help to diagnose and detect the progression of glaucoma, one of the leading causes of blindness in the U.S.

2 May 2018

New technique developed to improve diagnosis of vision disorders

A new technique that could help improve diagnosis of vision disorders has been successfully tested at the University of Bradford, UK.

2 May 2018

NTU Singapore and SERI team invents new 'pen camera' to detect patients with glaucoma

Scientists at Nanyang Technological University, Singapore, with clinicians from the Singapore Eye Research Institute, have invented a new 'pen camera' that makes it easier for doctors to diagnose patients with glaucoma.

5 Apr 2018

New discovery could help understand and treat glaucoma

Researchers have discovered two distinct groups of short molecules that regulate gene expression in the eyes of people with two different forms of glaucoma.

26 Feb 2018

Research provides new directions in understanding and fighting glaucoma

Two distinctive handfuls of short molecules that regulate gene expression have been found in the eye fluid of patients with two distinct types of vision degenerating glaucoma.

26 Feb 2018

Therapeutic target for glaucoma could have treatment ramifications for Alzheimer’s and Parkinson’s

A therapeutic target to preserve vision in glaucoma patients could have treatment ramifications for age-related neurodegenerative disorders like Alzheimer's and Parkinson's, according to findings released today in the Proceedings of the National Academy of Sciences.

20 Feb 2018

Dim light may affect your ability to learn and remember, suggests new study

A new study found that prolonged exposure to dim light may alter the brain's structure, and impair an individual’s ability to remember and learn.

6 Feb 2018

Glaucoma News and Research

Latest Glaucoma News and Research

Altitude sickness drug may offer significant gains for patients with glioblastoma

Ocular Therapeutix resubmits NDA for DEXTENZA

Scientists provide clear picture of mysterious component of the inner ear

UH scientist receives grant to examine understudied part of glaucoma

Persistent psychological stress contributes to development and progression of vision loss

Diabetes diagnosis may come with increased risk of pancreatic cancer for African-Americans, Latinos

EyeSouth announces strategic partnership with South Georgia / North Florida Eye Partners

Study reveals 133 genetic variants that may improve risk prediction for glaucoma

FDA approves first stand-alone prosthetic iris in the U.S.

Researchers seek new approaches to better protect the eye from glaucoma

Lack of insurance exposes blind spots in vision care

New lab-on-a-chip device shows promise in treating retinal diseases

Sylentis presents clinical study results of new treatment for dry eye syndrome

Researchers develop new methods to diagnose glaucoma and detect disease progression

New technique developed to improve diagnosis of vision disorders

NTU Singapore and SERI team invents new 'pen camera' to detect patients with glaucoma

New discovery could help understand and treat glaucoma

Research provides new directions in understanding and fighting glaucoma

Therapeutic target for glaucoma could have treatment ramifications for Alzheimer’s and Parkinson’s

Dim light may affect your ability to learn and remember, suggests new study

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Glaucoma News and Research

Latest Glaucoma News and Research

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Newsletters you may be interested in